OBJECTIVE: The objective of this study was to assess the predictive value of clinical and exercise test variables in patients with peripheral arterial disease (PAD). METHODS: A customized symptom-limited ramp treadmill protocol was used to assess 725 PAD patients referred for exercise testing at the Palo Alto Veterans Hospital between 1997 and 2011. Detailed clinical and exercise test data were collected at baseline, and patients were followed up for a mean of 11.3 ± 6.3 years. RESULTS: During follow-up, there were 364 deaths. Baseline exercise capacity was 7.0 ± 2.6 metabolic equivalents (METs) among survivors and 5.5 ± 2.4 METs in those who died (P < .001). Although several physiologic parameters differed between survivors and nonsurvivors, age-adjusted Cox regression revealed that exercise capacity was the strongest independent predictor of death. Each additional MET achieved was associated with age-adjusted 18% and 20% reductions in all-cause and cardiovascular mortality, respectively (P < .001 for both). This variable surpassed all classical risk factors (including smoking and history of congestive heart failure) and all measured exercise test responses (including symptoms and electrocardiograph abnormalities). CONCLUSIONS: Among PAD patients, reduced exercise capacity is the most powerful harbinger of long-term mortality. This factor has predictive power beyond traditional risk factors and confirms the critical importance of fitness in this cohort.
OBJECTIVE: The objective of this study was to assess the predictive value of clinical and exercise test variables in patients with peripheral arterial disease (PAD). METHODS: A customized symptom-limited ramp treadmill protocol was used to assess 725 PAD patients referred for exercise testing at the Palo Alto Veterans Hospital between 1997 and 2011. Detailed clinical and exercise test data were collected at baseline, and patients were followed up for a mean of 11.3 ± 6.3 years. RESULTS: During follow-up, there were 364 deaths. Baseline exercise capacity was 7.0 ± 2.6 metabolic equivalents (METs) among survivors and 5.5 ± 2.4 METs in those who died (P < .001). Although several physiologic parameters differed between survivors and nonsurvivors, age-adjusted Cox regression revealed that exercise capacity was the strongest independent predictor of death. Each additional MET achieved was associated with age-adjusted 18% and 20% reductions in all-cause and cardiovascular mortality, respectively (P < .001 for both). This variable surpassed all classical risk factors (including smoking and history of congestive heart failure) and all measured exercise test responses (including symptoms and electrocardiograph abnormalities). CONCLUSIONS: Among PAD patients, reduced exercise capacity is the most powerful harbinger of long-term mortality. This factor has predictive power beyond traditional risk factors and confirms the critical importance of fitness in this cohort.
Authors: Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith Journal: J Am Coll Cardiol Date: 2002-10-16 Impact factor: 24.094
Authors: Peter Kokkinos; Jonathan Myers; Charles Faselis; Demosthenes B Panagiotakos; Michael Doumas; Andreas Pittaras; Athanasios Manolis; John Peter Kokkinos; Pamela Karasik; Michael Greenberg; Vasilios Papademetriou; Ross Fletcher Journal: Circulation Date: 2010-08-09 Impact factor: 29.690
Authors: Andrew M Wilson; Amir H Sadrzadeh-Rafie; Jonathan Myers; Themistocles Assimes; Kevin T Nead; Mamie Higgins; Andre Gabriel; Jeffrey Olin; John P Cooke Journal: J Vasc Surg Date: 2011-06-12 Impact factor: 4.268
Authors: A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt Journal: JAMA Date: 2001-09-19 Impact factor: 56.272
Authors: Jonathan Myers; Manish Prakash; Victor Froelicher; Dat Do; Sara Partington; J Edwin Atwood Journal: N Engl J Med Date: 2002-03-14 Impact factor: 91.245
Authors: Timothy P Murphy; Donald E Cutlip; Judith G Regensteiner; Emile R Mohler; David J Cohen; Matthew R Reynolds; Joseph M Massaro; Beth A Lewis; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Michael R Jaff; Michael W Steffes; Anthony J Comerota; Jonathan Ehrman; Diane Treat-Jacobson; M Eileen Walsh; Tracie Collins; Dalynn T Badenhop; Ulf Bronas; Alan T Hirsch Journal: Circulation Date: 2011-11-16 Impact factor: 29.690
Authors: Mary M McDermott; Jack M Guralnik; Michael H Criqui; Kiang Liu; Melina R Kibbe; Luigi Ferrucci Journal: Circulation Date: 2014-07-01 Impact factor: 29.690
Authors: Breno Q Farah; Raphael M Ritti-Dias; Polly S Montgomery; Ana I Casanegra; Federico Silva-Palacios; Andrew W Gardner Journal: J Vasc Surg Date: 2015-10-27 Impact factor: 4.268
Authors: Mary M McDermott; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Melina R Kibbe; Philip Greenland; David Green; Kiang Liu; Lihui Zhao; John T Wilkins; Mark D Huffman; Sanjiv J Shah; Yihua Liao; Ying Gao; Donald M Lloyd-Jones; Michael H Criqui Journal: Vasc Med Date: 2016-02-12 Impact factor: 3.239
Authors: Harrie van den Bosch; Jos Westenberg; Wikke Setz-Pels; Erik Kersten; Alexander Tielbeek; Lucien Duijm; Johannes Post; Joep Teijink; Albert de Roos Journal: Int J Cardiovasc Imaging Date: 2016-05-21 Impact factor: 2.357